Plasma Protein Binding and Pharmacological Response

Clinical Pharmacokinetics

Volumn 24, Issue 6, 1993, Pages 435-440

  du Souich, Patrick ^a,b   Verges, Josep ^a,b   Erill, Sergio ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Esteve Foundation   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RECEPTOR; FUROSEMIDE; OROSOMUCOID;

DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INTERACTION; DRUG MECHANISM; EDITORIAL; HYPOALBUMINEMIA; PLASMA PROTEIN BINDING; PRIORITY JOURNAL;

BLOOD PROTEINS; HUMAN; PHARMACOKINETICS; PHARMACOLOGY; PROTEIN BINDING; RECEPTORS, DRUG; SERUM ALBUMIN;

EID: 0027197018     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/00003088-199324060-00001     Document Type: Article

References (22)

1. 1 acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation
2. Diphenylhydantoin side-effects and serum albumin levels
3. Determinants of response to furosemide in normal subjects
4. Resistance to diuretics: emphasis on a clinical perspective
5. Kinetics of drug action in disease states: II. Effect of experimental renal disfunction on phenobarbital concentrations in rats at onset of loss of righting reflex
6. Pharmacokinetic basis of variability in drug response: a study of tolbutamide in models of disease
7. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program
8. Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: a report from the Boston Collaborative Drug Surveillance Program
9. Drug protein binding and the nephrotic syndrome
10. Drug-protein binding in liver disease and in patients with hypoalbuminemia
11. Influence of plasma proteins on the onset of hypnotic action of intravenous midazolam
12. Mechanisms of furosemide resistance in analbuminemic rats and hypoalbuminemic patients
13. Effect of plasma protein binding of drugs and intensity of pharmacological activity
14. Decrease in Penbutolol central response as caused by changes in its serum protein binding
15. Abnormal pharmacokinetics of Phenytoin in a patient with uraemia
16. 1 acid glycoprotein and binding of basic drugs
17. Disease-induced changes in the plasma binding of basic drugs
18. Plasma protein binding displacement interactions are rarely of clinical significance
19. Diphenylhydantoin potency and plasma protein binding
20. Interindividual differences in drug-protein binding
21. Total and free propranolol levels in sensitive and resistant patients
22. Influence of changes in protein binding on the central activity of antidepressants